Lymphoma, T-Cell, Cutaneous
Showing 1 - 25 of 26
Skin Barrier and Microbiome of CTCL Patients
Not yet recruiting
- Lymphoma, T-Cell, Cutaneous
-
Leiden, NetherlandsCentre for Human Drug Research
Apr 21, 2023
Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)
Recruiting
- Lymphoma, T-Cell, Peripheral
- +4 more
- MT-101
- MT-101 + Conditioning (Lymphodepleting) Chemotherapy
-
Duarte, California
- +8 more
Jan 27, 2023
Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)
Active, not recruiting
- Mycosis Fungoides
- +2 more
- resminostat
- Placebo
-
Graz, Austria
- +53 more
Dec 12, 2022
Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma
Recruiting
- Lymphoma, T-cell, Peripheral
- Lymphoma, T-cell, Cutaneous
-
Nagoya, Japan
- +2 more
Nov 24, 2022
Response to Gemcitabine Chemotherapy in Mycosis Fungoides
Recruiting
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides
- single-arm, non-randomized Biodynamic imaging (BDI)
-
Indianapolis, IndianaIndiana University School of Medicine, Department of Dermatology
Nov 16, 2022
Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,
Terminated
- Mycosis Fungoides
- +2 more
- Naloxone Hydrochloride Lotion, 0.5%
- Placebo Lotion
-
Little Rock, Arkansas
- +15 more
Oct 26, 2022
Relapsed or Refractory CD30+ Malignancies When Re-treated With
Completed
- Hodgkin Disease
- Lymphoma, T-Cell, Cutaneous
- No Intervention
-
San Bartolome, Alicante, Spain
- +29 more
Jul 28, 2022
Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)
Active, not recruiting
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides/Sezary Syndrome
-
Madrid, Spain
- +1 more
Jul 1, 2022
Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid
Active, not recruiting
- Mycoses
- +5 more
- anti-thymocyte globulin
- +2 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 16, 2022
Tissue Repository: CTCL Collection Protocol
Recruiting
- Lymphoma, T-Cell, Cutaneous
- +2 more
-
New York, New YorkColumbia University Medical Center
May 2, 2022
Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse Trial in Spain (Registry of
Recruiting
- Lymphoma, T-Cell, Cutaneous
- +5 more
- Registry of patients (exposure is Cutaneous Lymphoma)
-
Barcelona, Spain
- +13 more
Mar 15, 2022
Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Zürich (Methoxsalen, THERAKOS CELLEX Photopheresis
Withdrawn
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides/Sezary Syndrome
- Methoxsalen
- THERAKOS CELLEX Photopheresis System
-
Zürich, SwitzerlandUniversitaetsSpital Zurich - Division of Dermatology
Aug 31, 2021
Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)
Terminated
- Lymphoma, T-Cell, Cutaneous
- +6 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jan 20, 2021
Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hodgkin Disease Trial in Chicago, Saint Louis (Romidepsin,
Completed
- Lymphoma, T-Cell, Cutaneous
- +3 more
- Romidepsin
- +4 more
-
Chicago, Illinois
- +1 more
Nov 16, 2020
Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)
No longer available
- Disease, Hodgkin
- +3 more
- brentuximab vedotin
-
Stanford, California
- +30 more
Sep 17, 2020
Lymphoma, T-Cell, Cutaneous Trial in New York (AFM13)
Completed
- Lymphoma, T-Cell, Cutaneous
-
New York, New YorkCenter for Lymphoid Malignancies
Jul 14, 2020
Lymphoma, T-Cell, Cutaneous Trial (Intratumoral G100)
Withdrawn
- Lymphoma, T-Cell, Cutaneous
- Intratumoral G100
- (no location specified)
Dec 16, 2019
Lymphoma, T-Cell, Cutaneous Trial in Bronx (Doxycycline, Imiquimod)
Unknown status
- Lymphoma, T-Cell, Cutaneous
-
Bronx, New YorkJames J Peters Bronx Veterans Affairs Medical Center
Aug 12, 2019
VircapSeq Virus Detection in Sézary Syndrome
Completed
- Lymphoma, T-Cell, Cutaneous
- Sézary Syndrome
-
New York, New YorkColumbia University Medical Center
Feb 6, 2017
Lymphoma, T-Cell, Cutaneous Trial in Worldwide (Quisinostat, 12 mg)
Completed
- Lymphoma, T-Cell, Cutaneous
- Quisinostat, 12 mg
-
Pittsburgh, Pennsylvania
- +12 more
Nov 2, 2016
Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi Trial in United States (SGN-30 (mAb))
Completed
- Hodgkin Disease
- +4 more
- SGN-30 (monoclonal antibody)
-
Birmingham, Alabama
- +9 more
Oct 7, 2011
